Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wei
Timothy D Henry

Showing results (601-610 of 754) with videos related to

Pageof 76
Sort By:
The American Journal of Cardiology|September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.
International Journal of Cardiology|June 11, 2011
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trialWilliam A Gray, Alan C Yeung, Donald E Cutlip, et al.
Circulation. Cardiovascular Interventions|September 17, 2017
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)Binita Shah, Usman Baber, Stuart J Pocock, et al.
Journal of Thrombosis and Thrombolysis|March 30, 2019
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
JACC. Cardiovascular Interventions|January 8, 2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)Ajay J Kirtane, Puja B Parikh, Thomas D Stuckey, et al.
Journal of the American College of Cardiology|April 16, 2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARISUsman Baber, Roxana Mehran, Gennaro Giustino, et al.
European Journal of Preventive Cardiology|March 11, 2026
Mortality score in chronic coronary syndrome: prediction model from the ISCHEMIA trialEliano P Navarese, Giuseppe Talanas, Dean J Kereiakes, et al.
Current Trends in Clinical & Medical Imaging|April 13, 2019
Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery DiseaseAhmed Al-Badri, Janet Wei, Sofy Landes, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|May 11, 2026
Feasibility and Impact of Invasive Coronary Function Testing in Ischemia and No Obstructive Coronary Arteries: A Single-Center StudyDeeksha Acharya, Yulith Roca Alvarez, Bruce Samuels, et al.
JACC. Cardiovascular Imaging|May 14, 2011
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery diseasePuja K Mehta, Pavel Goykhman, Louise E J Thomson, et al.
Pageof 76

Showing results (601-610 of 754) with videos related to

Sort By:
Pageof 76
The American Journal of Cardiology|September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.
International Journal of Cardiology|June 11, 2011
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trialWilliam A Gray, Alan C Yeung, Donald E Cutlip, et al.
Circulation. Cardiovascular Interventions|September 17, 2017
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)Binita Shah, Usman Baber, Stuart J Pocock, et al.
Journal of Thrombosis and Thrombolysis|March 30, 2019
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
JACC. Cardiovascular Interventions|January 8, 2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)Ajay J Kirtane, Puja B Parikh, Thomas D Stuckey, et al.
Journal of the American College of Cardiology|April 16, 2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARISUsman Baber, Roxana Mehran, Gennaro Giustino, et al.
European Journal of Preventive Cardiology|March 11, 2026
Mortality score in chronic coronary syndrome: prediction model from the ISCHEMIA trialEliano P Navarese, Giuseppe Talanas, Dean J Kereiakes, et al.
Current Trends in Clinical & Medical Imaging|April 13, 2019
Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery DiseaseAhmed Al-Badri, Janet Wei, Sofy Landes, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|May 11, 2026
Feasibility and Impact of Invasive Coronary Function Testing in Ischemia and No Obstructive Coronary Arteries: A Single-Center StudyDeeksha Acharya, Yulith Roca Alvarez, Bruce Samuels, et al.
JACC. Cardiovascular Imaging|May 14, 2011
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery diseasePuja K Mehta, Pavel Goykhman, Louise E J Thomson, et al.
Pageof 76